drugset / Trial / NCT03049930

Intraoperative Low-dose Ketamine Infusion as the Main Analgesic in Burn Patients

NCT03049930 ↗

Phase 4 Unknown 46 enrolled Loyola University
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether a low-dose ketamine infusion can be used as the main intra-operative analgesic in different burn patients, and thereby reduce the total intra-operative opioid requirement. Secondary objectives are to determine whether this low-dose ketamine infusion will lengthen the amount of time to the first narcotic given in the recovery room or ICU, and whether pain scores for awake patients will be lower post-operatively.

Timeline

Start
2018-02-27
Primary completion
2020-08
Completion
2020-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.2 mg/kg —

Indications

No indication recorded.